Olmutinib Inhibitor

MBS5759255 is an inhibitor targeting Olmutinib. Olmutinib is a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

Zhang W, Fan Y F, Cai C Y, et al. Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells[J]. Frontiers in Pharmacology, 2018, 9.
Zhang W, Fan Y F, Cai C Y, et al. Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells[J]. Frontiers in Pharmacology, 2018, 9.
Zhang Z, Fu L, Guo X, et al. Olmutinib (HM61713) reversed multidrug resistance by inhibiting the activity of ATPbinding cassette subfamily G member 2 in vitro and in vivo[J]. 药A-¦A-¦æŠ¥(è‹+/-æ-‡ç‰ˆ), 2018, 008(004):563-574.
Zhang Z, Fu L, Guo X, et al. Olmutinib (HM61713) reversed multidrug resistance by inhibiting the activity of ATPbinding cassette subfamily G member 2 in vitro and in vivo[J]. 2018, 008(004):563-574.

Small volumes of Olmutinib, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.